Lactocepin in the treatment of IP-10 mediated inflammatory diseases
The treatment of IP-10 mediated inflammatory diseases, especially inflammatory bowel diseases, is hampered by lack of treatment effects in some patients and a high frequency of adverse effects by current treatment approaches using steroids, non-steroidal anti-inflammatory drugs or immunosuppressants. Probiotic therapy is a new approach in order to reach this goal and has been shown to be effective in the context of many inflammatory diseases. Nevertheless, the underlying protective mechanisms and bacterial structural components are unknown, hampering the pharmaceutical use of probiotics.
<br> Lactocepins can be used as a pharmaceuticals or food supplement in the prevention and therapy of chemokine (IP-10)-mediated inflammatory disorders. Importantly, neutralization of IP-10 by an anti-IP-10 antibody has been shown to be an effective treatment in the context of experimental colitis and is currently investigated in a phase II clinical study, suggesting that selective cleavage of this proinflammatory chemokine by lactocepin is of high potential in the prevention and treatment of IP-10 mediated inflammatory diseases.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
How the Immune System Learns from Harmless Particles
Our lungs are bombarded by all manner of different particles every single day. Whilst some are perfectly safe for us, others—known as pathogens—have the potential to make us ill. The…
Biomarkers identified for successful treatment of bone marrow tumours
CAR T cell therapy has proven effective in treating various haematological cancers. However, not all patients respond equally well to treatment. In a recent clinical study, researchers from the University…
She deciphers how tomato roots communicate
Ora Hazak has always been fascinated by plants and is studying the signals that roots send to the rest of the organism. She aims to understand this communication in order…
